2148354-90-7
Chemical Structure
Tidutamab
Synonym(s): XmAb-18087
- CAS No.: 2148354-90-7
- Formula:N/A
- Molecular Weight:(150.74 kDa)
IUPAC Name: (4-(4-chlorobenzyl)tetrahydro-2H-pyran-4-yl)methanamine hydrochloride
SMILES: [Tidutamab]
Biological Activity: Tidutamab (XmAb-18087) is a humanized and affinity-optimized bispecific antibody (bsAb) targeting SSTR2 binding domain and T-cell binding domain (CD3). Tidutamab possesses a full Fc domain to maintain long serum half-life.Tidutamab eliminates SSTR+ tumor cells by stimulating redirected T cellmediated cytotoxicity (RTcC)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Tidutamab | 96.71% | Tidutamab (XmAb-18087) is a humanized and affinity-optimized bispecific antibody (bsAb) targeting SSTR2 binding domain and T-cell binding domain (CD3). Tidutamab possesses a full Fc domain to maintain long serum half-life.Tidutamab eliminates SSTR+ tumor cells by stimulating redirected T cellmediated cytotoxicity (RTcC). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords